Connection

JANET BUTEL to Mice, Transgenic

This is a "connection" page, showing publications JANET BUTEL has written about Mice, Transgenic.
Connection Strength

0.079
  1. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog. 1996 Apr; 15(4):261-9.
    View in: PubMed
    Score: 0.022
  2. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol. 1990 Dec; 64(12):5939-47.
    View in: PubMed
    Score: 0.015
  3. SV40 large T antigen directed by regulatory elements of the human alpha-1-antitrypsin gene. A transgenic mouse system that exhibits stages in liver carcinogenesis. Intervirology. 1990; 31(2-4):85-100.
    View in: PubMed
    Score: 0.014
  4. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. Cancer Res. 1989 Nov 01; 49(21):6108-17.
    View in: PubMed
    Score: 0.014
  5. Unscheduled DNA replication precedes apoptosis of photoreceptors expressing SV40 T antigen. Exp Eye Res. 1997 Apr; 64(4):573-85.
    View in: PubMed
    Score: 0.006
  6. The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol Cell Biol. 1994 Oct; 14(10):6743-54.
    View in: PubMed
    Score: 0.005
  7. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992 Mar 19; 356(6366):215-21.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.